Immunogenicity and immunological memory induced by a 7-valent pneumococcal CRM197 conjugate vaccine in symptomatic HIV-1 infected children

Vaccine

Volumn 23, Issue 46-47, 2005, Pages 5289-5293

  Spoulou, Vana I ^a   Tsoumas, Dimitris L ^a   Papaevangelou, Vana G ^a   Mostrou, Glykeria I ^a   Theodoridou, Maria C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Avidity; Children; Conjugate pneumococcal vaccine; HIV; Memory

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ANAMNESIS; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFICACY; GREECE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; MALE; PRIORITY JOURNAL; SEROTYPE; SIDE EFFECT; STATISTICAL MODEL; STREPTOCOCCUS INFECTION; SYMPTOM;

ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; CHILD; FEMALE; GREECE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; KINETICS; MALE; PNEUMOCOCCAL VACCINES; VACCINES, CONJUGATE;

EID: 27644570187     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.06.002     Document Type: Article

References (15)

1. CDC Preventing pneumococcal disease among infants and young children MMWR 49 2000 22
2. K. Klugman, S. Madhi, R. Huebner, R. Kohberger, N. Mbelle, and N. Pierce A trial of a 9-valent pneumococcal congugate vaccine in children with and those without HIV infection N Engl J Med 349 14 2003 1341 1348
3. L. Jodar, J. Butler, G. Carlone, R. Dagan, D. Goldblatt, and H. Käyhty Serological criteria foe evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants Vaccine 21 2003 3265 3272
4. D. Goldblatt, A.R. Vas, and E. Miller Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization J Infect Dis 177 1998 1112 1115
5. V. Spoulou, M. Theodoridou, V. Papaevangelou, G. Mostrou, and J. Ioannidis 23-Valent pneumococcal vaccination and HIV Lancet 356 2000 1027 1028
6. N.F. Conception, and C.E. Frasch Pneumococcal type 22 F polysaccharide absorption improves the specificty of pneumococcal polysaccharide enzyme-linked immunosorbent assay Clin Diag Lab Immunol 8 2001 266 272
7. A. Fry, R. Facklam, C. Whitney, B. Plikaytis, and A. Schuchat Multistate evaluation of invasive pneumococcal disease in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States J Infect Dis 186 2003 643 652
8. D. Feikin, C. Elie, M. Goetz, J. Lennox, G. Carlone, and S. Romero-Steiner Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal cojugate vaccine and/ or 23-valent polysaccharide vaccine among HIV-infected adults Vaccine 20 2002 545 553
9. D. Goldblatt, R. Borrow, and E. Miller Natural and vaccine-induced immunity and immunologic memory to Neiisseria memimgitidis serogroup C in young adults J Infect Dis 185 2002 397 400
10. M. Anttila, J. Eskola, H. Ahman, and H. Kayhty Differences in the avidity of antibodies evoked by four different pmeumococcal conjugate vaccines in early childhood Vaccine 17 1999 1970 1977
11. H. Baxendale, Z. Davis, H. White, M. Spellerberg, F. Stevenson, and D. Goldblatt Immunogenetic analysis of the immune response to pneumococcal polysaccharide Eur J Immunol 30 2000 1214 1223
12. T. Wuorimaa, H. Käyhty, O. Leroy, and J. Eskola Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults Vaccine 19 2001 1863 1869
13. V. Spoulou, D. Tsoumas, V. Papaevangelou, G. Mostrou, and M. Theodoridou Haemophilus influenzae type b conjugate vaccine-induced immunological memory in symptomatic HIV-infected children AIDS 17 9 2004 1396 1398
14. S.T. Sigurdardottir, K. Davidsdottir, and I. Jonsdottir IgG subclass responses to pneumococcal polysaccharide (PPS) booster 6 years after pneumococcal conjugate (Pnc) vaccination in Infancy. Effect of PPS Booster at 13 months Proceedings of fourth international symposium on pneumococci and pneumococcal diseases Helsinki, May 2004 [ISPPD-4, 2004, abstracts, p. 232]
15. C. Whitney, M. Farley, J. Hadler, L. Harrison, N. Benett, and R. Lynfield Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine N Engl J Med 348 18 2003 1737 1746